Abgent is a leading manufacturer of primary antibodies with more than a decade of experience. They meet the ever changing demands of research and drug discovery through a thoughtful target selection process and strengthened validation-standards. A focus lies on autophagy, stem cells, and neurodegeneration. Most antibodies are produced in-house to ensure specificity, affinity, and reproducibility. Antibodies that pass additional stringent quality requirements, including extended control sets, uniform results against multiple biologically relevant cell lines and tissues, and function in multiple applications are referred to as Crown antibodies.